Celiac Disease Foundation, the nation’s leading voluntary health organization for celiac disease, announces the appointment of four new members of its Board of Directors for the 2015-2017 term. Joining the Board of Director are Emily Luxford, Jody Morris, Jordan Ramer, and Jim Watson.
LOS ANGELES, Calif., Feb. 6, 2015 –Celiac Disease Foundation today sent a letter to California Attorney General Kamala Harris, asking that she issue notifications to GNC Holdings, Inc., Target Corporation, Walgreens and Wal-Mart Stores,…
Community Unites at Celiac Disease Foundation’s National Conference & Gluten-Free EXPO Life-Changing Opportunity for Individuals with Celiac Disease and other Gluten-Related Disorders in Pasadena, CA May 2-3 LOS ANGELES, CA…
Bloomberg News published an article today, “Puppies Trump Gluten in Super Bowl Ad Humor That Goes Too Far.” The Super Bowl ad, highlighting the return of NASCAR to NBC Sports, features comedian…
As we reflect on this past year, we want to thank you for your generous support, which has enabled us to achieve important advances in each of our key mission areas. CDF launched an Online Advocacy Program in order to encourage the public to bring celiac disease to the forefront of the nation’s healthcare agenda. We also unveiled a series of online tools, including a Symptoms & Conditions Checklist, a Healthcare Practitioner Directory, and a 7 Day Gluten-Free Meal Plan to aid in the diagnosis and treatment of celiac disease. Additionally, CDF provided a comprehensive didactic seminar at the National Education Conference this past June when Medical Directors from Alvine Pharmaceuticals, Quest Diagnostics, and LabCorp joined together for a biopharma panel to present information about advances in the screening and treatment of celiac disease.
Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...